Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-25 @ 12:39 AM
NCT ID:
NCT07120867
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed cancer and symptomatic patient with at least one of the following:
* Malignant pleural effusion confirmed by cytology.
* Recurrent exudative pleural effusion without an alternative diagnosis in the context of confirmed extrapleural cancer.
* Pleural effusion associated with hypermetabolic pleural thickening suggestive of malignant pleural effusion.
Exclusion Criteria:
* Radiological evidence of non-expandable lung
* Life expectancy \<1 month (LENT score: high risk)
* Previous ipsilateral lobectomy or pneumonectomy
* Previous ipsilateral chemotherapy or radiotherapy
* Presence of infected pleural effusion
* Patient preference for tunneled pleural catheter placement
* Pregnancy
* Thrombocytopenia or coagulopathy
* Contraindication to general anesthesia or sedation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07120867
Study Brief:
Protocol Section:
NCT07120867